|
BBOT BridgeBio Oncology Therapeutics Inc 1869105 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-56,454,000.00 |
| Balance Sheet |
|
Current Assets
|
$242,378,000.00 |
|
Assets
|
$376,706,000.00 |
|
Current Liabilities
|
$51,634,000.00 |
|
Liabilities
|
$53,594,000.00 |
|
Equity
|
$323,112,000.00 |
|
Shares Out
|
80115002.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-80,278,000.00 |
|
Investing Cash Flow
|
$-239,678,000.00 |
| Market Analysis |
Market Cap
|
$727,444,218.16 |
|
Price
|
$9.08 |
|
BVPS
|
4.03 |
|
PB
|
2.25 |
|
EPS
|
-705.20 |
|
FCF
|
$-80,349,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:28 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.49 |
|
|
2026-05-12 |
-526.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BBOT documents filed with the SEC.
BBOT Filings
Clear
